Frankfurter Str. 63-69, Eschborn 65760

+49 6196 5835285

PROF. (KR) DR. SVEN LEE

As an expert in eye surgery with laser technology, Dr. Sven Lee practices at the Laser Zentrum at MVZ AUREGIO in Düsseldorf and, since 2023, also in his own practice in Eschborn. For this, he can draw on a wide range of experience:


Dr. Sven Lee developed the ASA80 or ASA-Lasek procedure (including software) together with colleagues.


As the son of a specialist in pediatrics, adolescent medicine and radiology, he learned early on how important it is to help people medically. Having undergone eye surgery himself, he understands the importance of good vision to human life.


Dr. Sven Lee is the only German-born Korean who has been a full-time professor at the University Eye Hospital in Seoul.

 
PROF. (KR) DR. SVEN LEE

MY CURRICULUM VITAE

Since 2002

Lectures and scientific work in Germany,

Europe, Asia, USA, China

Since 2003

Professor at Chungang University Seoul, Korea, Department of Ophthalmology, Division of Cataract and Refractive Surgery

Since 2004

Discussant of ASCRS (American Society of Cataract and Refractive Surgery)

Since 2017

Shanghai New Vision Eye Ophthalmology Hospital

Since 2020

AUREGIO Day Clinic Düsseldorf

AWARDS TO DATE

- ASCRS (American Society of Cataract and Refractive Surgery): best presentation / speech of conference, keto-refractive presbyopia: laser-based: 2010


- ASCRS (American Society of Cataract and Refractive Surgery): best poster/illustration of conference, keto-refractive Presbyopia: intra-ocular surgery: 2010

More interesting information

Curriculum vitae

  • Study of human medicine at the Johannes Gutenberg University Mainz
  • Doctorate at the Hannover Medical School
  • Since 2002 Lectures and scientific work in Germany, Europe, Asia, USA, China
  • Since 2003 Professor at Chungang University Seoul, Korea, Department of Ophthalmology, Division of Cataract and Refractive Surgery
  • From 2004: Panelist at the ASCRS (American Society for Cataract and Refractive Surgery)
  • As of 2017.Shanghai New Vision Eye Ophthalmology Hospital  
  • From 2020, AUREGIO DAY CLINIC DÜSSELDORF
  • Awards:
  • ASCRS (American Society for Cataract and Refractive Surgery): Best Paper of Session, Keratorefractive Presbyopia: Laser Based: 2010
  • ASCRS (American Society for Cataract and Refractive Surgery): Best Poster of Session, Keratorefractive Presbyopia: Intraocular Surgery: 2010  

Memberships, patent application

  • E.L.E.O.S (Excimer Laser European Ophthalmic Society): ab 2001.
  • ESCRS (European Society of Cataract and Refractive Surgery, ASCRS (American Society of Cataract and Refractive Surgery), DOG (Deutsche Ophthalmologische Gesellschaft), SOE (European Society of Ophthalmology), AAO (American Academy of Ophthalmology), KSCRS (Korean Society of Cataract and Refractive Surgery, APAO (Asia-Pacific Academy of Ophthalmology Congress): ab 2002.
  • Software Entwicklung (ASA80) eines Steueralgorithmus zur Veränderung der sphärischen Aberratio

Excerpt lectures, panelist

  • Painfree PRK with fast visual Recovery. ESCRS in Nice, France. 2002
  • Cooling techniques during PRK. ESCRS in Nice, France. 2002
  • Cooling during PRK. AAO and ISRS in Orlando, USA. 2002
  • Painfree PRK with fast visual Recovery. AAO and ISRS in Orlando, USA. 2002
  • Painfree PRK with fast Visual Recovery. ASCRS in Philadelphia, USA. 2002
  • New Cooling techniques during PRK. ELEOS in Strasbourg, France. 2002
  • Advanced Surface Ablation (ASA80) in Excimer Laser Refractive Surgery. ESCRS in Munich, Germany. 2003
  • Comparison of First Clinical Results of the Advanced Surface Ablation (ASA80) with the MEL80 vs. MEL70. Zeiss Symposia in Munich, Germany. 2003
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ESCRS in Barcelona, Spain. 2004
  • Where is the limit for successful and safe Myopic Surface Ablation? Statistical analysis of 556 treated eyes. ESCRS in Barcelona, Spain. 2004
  • Customized correction of spherical aberrations (Zernike (* 0)) with the Advanced Surface Ablation using the MEL80 (ASA80). ESCRS in Barcelona, Spain. 2004
  • Wavefront guided correction of Presbyopia. ESCRS in Barcelona, Spain. 2004
  • Comparative Study of Treatment of the Dry Eye Syndrome due to Disturbances of the Tear Film Lipid Layer with Lipid-Containing Tear Substitutes Efficacy of lipid-containing tear substitutes. ESCRS in Paris, France. 2004
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ESCRS in Paris, France. 2004
  • Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. ESCRS in Paris, France. 2004
  • Advanced Surface Ablation (ASA80). A new approach to Excimer-Laser-Surface Ablation for the correction of myopia. Statistical comparison with standard PRK. ESCRS in Paris, France. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. ESCRS in Paris, France. 2004
  • Customized correction of spherical aberrations (Zernike (* 0) with the Advanced Surface Ablation using the MEL80 (ASA80). Zeiss Symposia in Barcelona, Spain. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. Zeiss Symposia in San Diego, USA. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 12 months follow-up. Zeiss Symposia in New Orleans, USA. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 12 months follow-up. AAO and ISRS in New Orleans, USA. 2004
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis of 237 treated eyes. ASCRS in San Diego, USA. 2004
  • Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. ASCRS in San Diego, USA. 2004
  • Advanced Surface Ablation (ASA80). A new approach to Excimer-Laser-Surface Ablation for the correction of myopia. Statistical comparison with standard PRK. ASCRS in San Diego, USA. 2004
  • Wavefront guided correction of Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80). 2-9 months follow-up. ASCRS in San Diego, USA. 2004
  • Panelist in Session 2-J: Keratorefractive Epi-Lasik, Lasik, PRK. ASCRS in San Diego, USA. 2004
  • A new therapy concept with a liposome eye spray for the therapy of the "dry eye". First clinical results of a statistical analysis of a long-term study. DOG in Berlin, Germany. 2004
  • Where is the limit for successful and safe myopic surface ablation? Statistical Analysis of 556 treated eyes. AAD in Duesseldorf, Germany. 2004
  • Wavefront Guided Correction of Presbyopia with ASA80: 2 years follow up. Zeiss Symposia in Chicago, USA. 2005
  • Advanced Surface Ablation (ASA80) today. International MEL80 Symposium in Bangkok, Thailand. 2005
  • Statistical Analysis of Presbyopia Treatments. International MEL80 Symposium in Bangkok, Thailand. 2005
  • Clinical aspects and patient selection for presbyopia treatments. International MEL80 Symposium in Bangkok, Thailand. 2005
  • Presbyopia Correction with the MEL * Statistical Analysis of Clinical Outcomes. AAO and ISRS in Chicago, USA. 2005
  • Complications and Treatment of Diabetic Retinopathia. DOG in Berlin, Germany. 2005
  • New Advances in Cataract Surgery today. DOG in Berlin, Germany. 2005
  • Wavefront guided correction of Contrast Sensitivity, Mesopic Contrast Sensitivity and Presbyopia with Advanced Surface Ablation using the MEL 80 (ASA80®). The 7th Refractive Symposium at the Catholic University in Seoul, Korea. 2005
  • Altering Zernike Polynomials to Correct Presbyopia and Quality of Vision Results (ASA80). ASCRS in San Francisco, USA. 2006
  • Wavefront Guided Correction of Presbyopia, Contrast Sensitivity and Mesopic Contrast Sensitivity: 2 Year Follow up. ASCRS in San Francisco, USA. 2006
  • Panelist in Session 4-C: Wavefront, New Technology. ASCRS in San Francisco, USA. 2006
  • Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer. SOE Congress in Berlin, Germany. 2006
  • Comparative study of the therapy of dry eye syndrome with artificial tear substitutes especially for the treatment of the disturbance of the lipid layer. Chinese Academy of Sciences in Shanghai, China. 2006
  • Presbyopia Correction with the MEL80 Using ASA80®/ASA Lasek®: Statistical Analysis of clinical outcomes: 3 year follow-up of a Multicenter Study. Turkish Refractive Surgery Symposium in Antalya, Turkey. 2006
  • Correction of Presbyopia and Contrast Sensitivity with the MEL 80 Using ASA80®/ASA Lasek®: Statistical Analysis of clinical outcomes. 3 year follow-up of a Multicenter Study. APAO in Singapore, Singapore. 2006
  • New aspheric profiles with alternated Zernike Polynomials to improve Presbyopia and Night Vision Problems, esp. in high myopic patients with Advanced Surface Ablation (ASA-Lasek). ESCRS in Stockholm, Sweden. 2007
  • Wavefront Guided Correction of Presbyopia, Contrast Sensitivity, Mesopic Contrast Sensitivity with Advanced Surface Ablation (ASA80): 3 year follow-up. ESCRS in Stockholm, Sweden. 2007
  • Advanced Surface Ablation using a Spot-Scanning-Excimer Laser (ASA80): Statistical Comparison of results with standard laser profiles and new aspheric ablation profiles with altered Zernike Polynomials. ESCRS in Stockholm, Sweden. 2007
  • Creating monovision on the non-dominant eye for the correction of presbyopia by altering Zernike Polynomials. A new approach: 1 year follow-up. ESCRS in Berlin, Germany. 2008
  • Treatment of high myopia and hyperopia with wavefront-guided advanced-surface-ablation (ASA-Lasek®). Increasing the depth-of-field with aspheric-shoffiles: 2 year-follow-up. ESCRS in Berlin, Germany. 2008
  • Wavefront-Guided Correction of Presbyopia, Contrast Sensitivity, and Mesopic Contrast Sensitivity with Advanced Surface Ablation: Four-Year Follow-up. ASCRS in Berlin, Germany. 2008
  • Design of New Aspheric Ablation Profiles with Modified Zernike Polynomials to Improve Presbyopia and Night Vision Problems. ASCRS in Chicago, USA. 2008
  • Panelist in Session 4-C: Wavefront, New Technology, ASCRS in Chicago, USA. 2008
  • Micromonovision on the non-dominant eye for the correction of presbyopia by altering Zernike Polynomials: new approach - 2 years follow-up. ESCRS in Barcelona, Spain. 2009
  • Presbyopia correction with AcrySof ReSTOR, CustomVue monovision, and wavefront-guided monofocal ablation: comparative analysis. ESCRS in Barcelona, Spain. 2009
  • Statistical comparison of presbyopia correction with wavefront-guided advanced surface ablation, CustomVue monovision LASIK, and multifocal ReSTOR IOLs. ESCRS in Barcelona, Spain. 2009
  • Correction of high refractive errors with wavefront-guided advanced-surface-ablation (ASA-LASEK): increasing the depth-of-field with aspheric-shoffiles- 3 year follow-up. ESCRS in Barcelona, Spain. 2009
  • Creating Micromonovision in the Nondominant Eye for the Correction of Presbyopia by Altering Zernike Polynomials: Eighteen-Month Follow-up. ASCRS in San Francisco, USA. 2009
  • Treatment of High Myopia and Hyperopia with Wavefront-Guided Advanced Surface Ablation Increasing the Depth-of-Field with Aspheric Shotfiles: Three-Year Follow-up. ASCRS in San Francisco, USA. 2009
  • Approaches to Presbyopia Correction: Comparative Analysis of Wavefront-Guided Monofocal Ablation, Multifocal IOLs, and Monovision: Two-Year Results. ASCRS in Boston, USA. 2010
  • Wavefront Correction of High Refractive Errors with Aspheric Shotfiles to Increase Depth-of-Field ASA LASEK: Three-Year Results. ASCRS in Boston, USA. 2010
  • Panelist in Session 2-O: Keratorefractive Surface Ablation, ASCRS in Boston, USA. 2010

Excerpt scientific papers/publications

  • “Das Trockene Auge“. 2003. Deutsche Gesundheitshilfe e.V.
  • “Where is the limit for successful and safe myopic surface ablation? Statistical analysis of 556 treated eyes”. Augenspiegel 2004    
  • “Ein neues Therapiekonzept zur Behandlung des Trockenen Auges – Die Verwendung von Phospholipid-Liposomen“
    “A New Therapy Concept with a Liposome Eye Spray for the Treatment of the Dry Eye”. Klinische Monatsblätter für Augenheilkunde, 2004.
  • “Vergleichende Studie zur Therapie des Trockenen Auges bedingt durch Lipidphasenstörungen mit lipidhaltigen Tränenpräparaten. Zur Wirksamkeit lipidhaltiger Tränenpräparate”. “Comparative Study of Treatment of the Dry Eye Syndrome due to Disturbances of the Tear Film Lipid Layer with Lipid-Containing Tear Substitutes. Efficacy of lipid-containing tear substitutes”. Klinische Monatsblätter für Augenheilkunde, 2006
  • “Therapie des Trockenen Auges“/ “Advances in the therapy of the Dry Eye Syndrome“, Ophthalmologische Nachrichten, 2005.
  • Where is the limit for successful and safe hyperopic surface ablation? Statistical analysis of 237 treated eyes. Journal of the European Society of Cataract and Refractive Surgery, 2004.
  • Rigorous statistical analyses prove upper limit for safe, successful hyperopic PRK. Journal of the European Society of Cataract and Refractive Surgery, 2005.
  • Less Pain more gain with Advanced Surface Ablation. Journal of the European Society of Cataract and Refractive Surgery, 2005.
  • Where is the limit for successful and safe Hyperopic Surface Ablation? Statistical analysis, Ocular Surgery News, 2004.
  • Where is the limit for successful and safe Myopic Surface Ablation? 3-Year-Follow-Up. Statistical analysis of 446 treated eyes. Ocular Surgery News, 2005
  • ASA80 (Advanced Surface Ablation using the MEL80) approach shows advantages over PRK. Ophthalmology Times, 2004.
  • Manual for the MEL80: “Step by Step Manual for Advanced Surface Ablation”. Refractive Newsletter Carl Zeiss Meditec, 2003.
  • Improving Contrast Sensitivity with Shifting of the Spherical Aberration to Sustain Corneal Prolaticity. Refractive Newsletter Carl Zeiss Meditec, 2005. 
  • Wavefront Guided Correction of Presbyopia – German Multicenter Statistical Analysis. Refractive Newsletter Carl Zeiss Meditec, 2006.
Oculight

FOR A LIFE
WITHOUT GLASSES

Prologue

Brilliant prospects - a life without glasses, without contact lenses. Dr. Sven Lee specializes in the surgical correction of refractive errors, such as nearsightedness, farsightedness, astigmatism and presbyopia. 


The medical term for this is "refractive eye surgery". It goes without saying that our quality standards meet the highest demands. 


Thus, your health, your safety and your well-being have absolute priority for us. 

The eye

Your healthy eye


The cornea (transparent cornea) is part of the outer shell of the eye. Behind it lies the iris (colored iris). In the center of the eye is the pupil, which is visible as a round opening and behind which is the transparent lens. The retina forms the inner layer of the eye.


Sharp vision


Your eye works much like a camera: light enters the eye through the cornea, passes through the lens, and hits the retina at the exact center of the retina in the eye that sees in focus. The pupil ensures that the right amount of light always enters the eye by enlarging or shrinking accordingly. Flattening or bulging of the lens ensures that a sharp image is formed - depending on whether near or distant objects are perceived by the eye. The retina corresponds to the film of a camera. The light rays are projected from the lens onto the retina. The brain receives its information via the retina's photoreceptors, where the image finally takes shape.

 
oculight

FORMS OF MYOPIA

NEARSIGHTEDNESS

The nearsighted eye can only perceive objects sharply that are in the near range. The cornea and the retina are too far apart. Instead of being focused on the retina, the light rays are focused in front of it and then disperse again. The medical term for nearsightedness is "myopia".

FARSIGHTEDNESS

The far-sighted eye is built too small. The light rays are only focused behind the retina. The medical term for long-sightedness is »hyperopia«.

CORNEAL CURVATURE

The normal cornea, in conjunction with the crystalline lens at the back of the eye, produces a largely point-shaped image. In the case of more severe corneal curvatures and irregularities, this image is distorted in the shape of a line. Aberrometry measurement allows these distortions to be measured and corrected with excimer lasers of the latest generation. The medical term for corneal curvature is "astigmatism".

PRESBYOPIA

Presbyopia is the progressive age-related loss of the eye's ability to adjust to near vision by means of accommodation. There are surgical options, e.g. through the implantation of artificial lenses or the SUPRACOR procedure, which make near vision possible again.


Surface treatments: Photorefractive Keratectomy (PRK), No Touch Trans-PRK and Laser Epithelial Keratomileusis (LASEK).

PRK is the oldest procedure in laser eye surgery (since 1987). It is suitable for correction of myopia up to max. -8 diopters, hyperopia up to max. +3 diopters and astigmatism up to -6 diopters.


First, the top layer of the cornea, the epithelium, is removed mechanically or by laser (Trans PRK). Then, the center of the cornea is ablated with the excimer laser to compensate for the refractive error. At the end of the surgery, a special funnel is used to cool the cornea. The epithelium re-forms under a contact lens in a few days and closes the superficial wound. PRK, LASEK and trans-PRK are essentially the same.

What requirements should be met for the laser intervention?

  • Age: at least 18 years old
  • The refractive error should not have changed for at least 2 years
  • Diseases such as glaucoma or cataract must not be present.
  • Sufficient corneal thickness
  • No surgery should be performed during pregnancy or breastfeeding.
  • The purpose of the careful and comprehensive preliminary examination is to exclude all foreseeable risks. This is how we determine whether you are suitable for laser treatment.

How promising is the result of LASEK surgery in the long run?

The methods have been used millions of times for decades and are scientifically recognized laser procedures with very stable long-term results.

Are there any risks associated with the LASEK procedure?

The risks associated with both methods are low. 


If some results of the preliminary examination are negative, we advise patients not to undergo laser surgery. 

Alternative methods

ICL (implantable contact lens)

During this procedure, an artificial lens is inserted into the eye through a small incision and implanted between the natural lens and the iris. This lens corrects myopia up to -20 diopters, hyperopia up to +10 diopters and astigmatism up to - 6 diopters. In the other lens surgery procedures, the lenses are attached to the iris or in the chamber angle in front of the natural lens.

RLA (refractive lens exchange)

In refractive lens exchange, also called refractive lens exchange (RLE) or clear lens exchange (CLE), the natural lens of the eye is removed and replaced with a multifocal or accommodative artificial lens. The procedure is suitable for the correction of myopia up to a maximum of -30 diopters, hyperopia up to a maximum of +20 diopters and astigmatism up to approximately -12 diopters.


The procedure is identical to cataract surgery, the most common surgical procedure in medicine. It is therefore extremely standardized and safe. The difference with cataract surgery is that the lens is still relatively clear but dysfunctional, and it is exchanged to compensate for an existing defect as well as presbyopia. This operation can be performed conventionally with a blade and an ultrasound device. More gentle and incomparably more precise is the operation with the femtosecond laser. This advanced procedure ensures optimal anchoring and centering of the artificial lens. 


After the healing process is complete (3-6 months), any residual refractive errors such as astigmatisms or aberrations can be corrected with the excimer laser. The combined eye surgery method of LASEK and lens surgery is also called BIOPTIK.


Refractive lens exchange (RLA) is so far the best and most reliable surgical procedure to make reading or varifocal glasses unnecessary.

SUPRACOR METHOD FOR THE TREATMENT OF PRESBYOPIA WITH LASEK

The SUPRACOR procedure was developed by Technolas Perfect Vision, a world leader in laser eye surgery. With the SUPRACOR laser procedure, the AUREGIO Laser Center now offers a state-of-the-art possibility to have presbyopia treated with an excimer laser in combination with LASEK. With the SUPRACOR laser procedure, you can lead a life without reading glasses in the future. With Supracor, the cornea of both eyes is treated equally for distance and near vision. That is why we speak of multifocal treatment.

Quality check

The quality of the laser treatment of your eyes and thus the safety of the treatment and consequently the quality of your vision for the rest of your life depend decisively on the technique used and the experience of your surgeon. In the */85following, we have compiled a checklist that should help you to recognize, on the basis of a few *targeted questions, where you can have an operation carried out without any worries and which offers are, at first glance, possibly inexpensive but ultimately inferior forms of treatment whose 'price advantage' is to be sought, among other things, in the use of an outdated technique.

Consultation and preliminary examination

The foundation for a successful treatment is laid by a conscientious, thorough examination of your eyes. Based on these results, the appropriate procedure that can meet your needs and requirements will be determined together with you in a detailed discussion and all risks as well as chances will be openly discussed.

Iris recognition

An iris recognition system (iris photo based on future biometric passport data) is used to identify the patient. 


passport data), the patient is recognized, the corresponding preliminary examinations in which the iris was recorded are assigned, and personalized treatment is initiated and guaranteed. The safety gain is that neither the patient nor the eyes can be confused.

Eye torsion compensation (rotation compensation)

An iris recognition system (iris photo based on future biometric passport data) is used to identify the patient. passport data), the patient is recognized, the corresponding preliminary examinations in which the iris was recorded are assigned, and personalized treatment is initiated and guaranteed.


The safety gain is that neither the patient nor the eyes can be confused.

Pupil measurement in twilight (Procyon pupillometer) 

In order to see well at dusk and in the dark, the treated area must be at least as large as the pupil diameter in twilight. Even if one does not suspect it, patients often have large pupils when measured accurately under night conditions, so that here laser treatment with older devices can lead to night driving problems 


(e.g. halos) may occur.

Operation by
an experienced surgeon

A high level of professionalism, precision and reliability is guaranteed by Dr. Sven Lee with experience of more than 20 years and a case number of more than 40,000 with the LASEK method. Important in this context is the consultation, preliminary examination and surgery by one and the same doctor.

Quality assurance  

The surgical standards are regularly controlled, taking into account all known guidelines (especially the quality assurance of the Commission of Refractive Surgery). The patient and the quality of the surgery are the highest priority for Dr. Sven Lee.

PROF.(KR) DR. SVEN LEE

MEMBERSHIPS & PATENT APPLICATIONS

  • E.L.E.O.S (Excimer Laser European Ophthalmic Society): since 2001.

  • ESCRS (European Society of Cataract and Refractive Surgery, ASCRS (American Society of Cataract and Refractive Surgery), DOG (Deutsche Ophthalmologische Gesellschaft), SOE (European Society of Ophthalmology), AAO (American Academy of Ophthalmology), KSCRS (Korean Society of Cataract and Refractive Surgery, APAO (Asia-Pacific Academy of Ophthalmology Congress): since 2002.

  • Software development (ASA80) of a control algorithm to change the spherical aberration (especially Zernike Z(4,0) for the MEL80 excimer laser from Carl Zeiss Meditec, 2004.
PROF.(KR) DR. SVEN LEE

COSMETIC SERVICES

  • Upper eyelid lift
  • Wrinkle treatment
  • benign skin changes, pigment spots, lentigo, warts, fibromas, milia, xanthelasma, keloids
  • Hyaluron injections, Botox treatments

MitoEnergy infusion for the regeneration of mitochondria.


Mitochondria are the power plants of all living beings and produce energy in the form of adenosine triphosphate (ATP) continuously. Mitochondria perform many vital functions for the cell. In addition to oxygen, they also require glucose, amino acids, fatty acids, minerals, vitamins and nucleic acids.



Counteracting mitochondrial dysfunction


Scientific evidence has shown for several years that neurological, metabolic, cardiac, immunological and oncological diseases are increasingly associated with acquired dysfunction of mitochondria as a major cause. In particular, tissues that are highly energy dependent, such as the nervous system, heart, and musculature, rely on an adequate supply of energy from mitochondria. Acquired dysfunction of mitochondria can nowadays be reliably determined by laboratory chemistry.


What does the MitoEnergyBasis infusion contain and do?


The goal of the treatment is the regeneration of mitochondria, the so-called mitochondrial biogenesis: the activation and new formation of mitochondria. For this purpose, we use the MitoEnergyBasis infusion according to the formula of the Arnika pharmacy in Unterhaching. This formula contains in high concentrations vitamin C, reduced glutathione, carnosine, magnesium, L-arginine, taurine, glycine, lysine, N-acetyl-tyrosine, potassium-magnesium-aspartate, vitamins B1, B2, B3, B5, B6, adenosylcobalamin, hydroxycobalamin and methylcobalamin.


All these substances have a synergistic effect on the function of mitochondria. The undisturbed function is not only important for the production of energy, but also essential for endogenous detoxification as well as immunological processes. The infusions are administered simultaneously with the me2.vie system therapy. High-frequency stimulation currents have a positive influence on cell and mitochondrial membrane structures and measurably improve the supply of nutrients to the mitochondria.

Services

OPHTHALMOLOGY PRACTICE DR. SVEN LEE

Book your personal appointment at the Oculight practice and learn

which treatments can improve your vision.

LASER OPERATIONS

RENOWNED OPHTHALMOLOGIST

Dr. Sven Lee studied at the Johannes Gutenberg University in Mainz, Germany, and can look back on a large number of internationally recognized scientific publications, lectures and awards.


He has worked in private clinics and as an ophthalmologist in Korea and Shanghai, among other places.


Dr. Sven Lee specializes in all procedures performed with the excimer laser. In his surgeries, Dr. Lee uses the latest generation excimer lasers, including TENEO(TM) 317 MODEL 2 from BAUSCH + LOMB GmbH.


In his spare time, he enjoys hobbies such as skydiving, boxing, soccer, fitness, jogging, and playing the piano.

Dr. Sven studied at the Johannes Gutenberg University in Mainz, Germany, and can look back on a large number of internationally recognized scientific publications, lectures and awards.


He has worked in private clinics and as an ophthalmologist in Korea and Shanghai, among other places.


Dr. Sven Lee specializes in all procedures performed with the excimer laser. In his surgeries, Dr. Lee uses the latest generation excimer lasers, including TENEO(TM) 317 MODEL 2 from BAUSCH + LOMB GmbH.


In his spare time, he enjoys hobbies such as skydiving, boxing, soccer, fitness, jogging, and playing the piano.

 
Contact

WE INFORM YOU GLADLY

If you want to know more about our practice, our equipment or possible treatments, you can write an email, write on Whats-App, call us or use our contact form: